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The aim of this study is to evaluate the effect of polyethylene glycol brij ethers surfactants group on 
red blood cells as a model for biological membranes. Also in this study, physicochemical properties 
including emulsification index (E24), foam producing activity (Fh) and critical micelle concentration 
(cmc) were studied. Surfactant solutions were prepared in McIvan’s buffer in specific concentrations. 
0.2 ml of red blood cells (RBC) was mixed with 0.2 ml of each surfactant solution. The four surfactant 
solutions had each been incubated differently at two different temperatures for three different times. 
Each test was done six times. The results were presented as mean absorbance ± the standard 
deviation. E24, Fh and cmc were also determined for each surfactant solution. All of the surfactant 
solutions showed hemolytic activity. In comparison with the four studied surfactants, brij 56 had the 
highest hemolytic effect and brij 72 the lowest. The values of E24 and Fh had good correlation with 
hydrophilic-lipophilic balance values. According to the results of this study, brijs should be used at 
concentrations lower than cmc in formulations. Also, according to the results, the use of brijs with low 
hemolytic effect such as brij 72, is preferred in pharmaceutical preparations. 
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INTRODUCTION 
 
Surfactants have many characteristics comprising groups 
with hydrophilic and hydrophobic characters. They have 
different uses in pharmaceutical formulations, such as co- 
solvent, humectant,  emulsifying,  solubilizing  agent  and 
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Abbreviations: E24, Emulsification index; Fh, foam producing 
activity; Brij 52, polyoxyeethylene2cetylether; Brij 56, polyoxy-
eethylene10cetylether; Brij 72, polyoxyeethylene- 2stearylether; 
Brij 92, polyoxyeethylene2oleylether;  HLB, hydrophile-lipophile 
balance;  cmc, Critical Micelle Concentration. 
enhancer.  Regarding their hydrophilic part, they are divided 
into four groups: anionic, cationic, amphoteric and non-
ionic (Dehghan Noudeh et al., 2008). 
Absorption enhancing ability of surfactants in formula-
tions with low absorption like peptides or proteins is used 
for drug delivery in non-injectable formulations. Broad 
spectrums of surfactants are used as enhancers including 
bile salts, anionic detergents, glycerides and lysophos-
pholipids (lysolecithins); however, the efficacy of non-
ionic surfactants with moderate polarity is better. On the 
other hand, it is reported that non-ionic polar surfactants 
do not have toxicity, while surfactants with moderate 
polarity showed toxic effects (Gould, 2000). 
Morphological and biochemical studies on the membrane  
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absorption sites showed that surfactants enhance 
membrane transport followed by acute toxicity, but these 
effects were reversed after a long time. As a result, there 
is a pivotal relationship between permeability enhance-
ment activity and acute toxicity. Moreover, permeability 
enhancing effect of surfactants is not only related to their 
nature, but also depends on other characteristics like 
electrical charge, polarity and the membrane (Galembeck 
et al., 1998; Gould, 1996). 
Permeability enhancers are agents that decrease or 
remove extra cellular layer resistance reversibly and 
allow the drug to pass through and between epithelial 
cells towards blood and lymph. Recently, enhancing drug 
permeability through cellular membrane has become one 
of the main topics in pharmaceutical research (Muranishi, 
1990).  
Gould, (1996) showed that some non-ionic surfactants 
could increase mucosal absorption of drugs with low 
absorption. One of the suggested mechanisms is inducing a 
partial but reversible gap within cell membranes' and 
consequently increasing the permeability by surfactants 
or other enhancers. Various models exist for evaluation 
of membrane toxicity of surfactants including single cell 
models using erythrocytes, erythrocyte ghosts, or lipo-
somes. The erythrocyte model has been widely used as it 
presents a direct indication of toxicity of injectable 
formulations as well as general indication of membrane 
toxicity. Another advantage of the erythrocytes model is 
that blood is readily available and that cells are easy to 
isolate from the blood; moreover, its membrane has 
similarities with other cell membranes (Gould, 1996). 
Evaluating the toxicity of permeability enhancers using 
biological membranes plays an important role in current 
pharmaceutical research. Consequently, in the present 
study we decided to determine the effects of poly-
oxyeethylene polyoxyeethylene2cetylether (Brij 52), poly-
oxyeethylene10cetylether (Brij 56), polyoxyeethylene2-
stearylether (Brij 72) and polyoxyeethylene2oleylether 
(Brij 92) on cellular membrane using the erythrocyte 
model. 
 
 
MATERIALS AND METHODS  
 
Materials 
 
All materials were of reagent grade unless otherwise mentioned. 
Brij 52, Brij 56, Brij 72 and Brij 92 were prepared from Fluka 
(Netherlands). Sodium chloride, di-sodium hydrogen phosphate, 
citric acid (monohydrate), di-sodium phosphate and liquid paraffin 
were purchased from Merck (Germany). Drabkin's agent was 
supplied from Chimi-Daru (Iran). 
 
 
Buffer and reagents preparation 
 
McIlvaine's buffer was prepared as follows: Solution 1, containing 
21 g of citric acid (100 mmol) and 8.775 g of sodium chloride (150 
mmol) made up to 1000 ml with deionized water, was mixed with 
solution 2, containing 28.4 g of di-sodium hydrogen phosphate (200  
 
 
 
 
mmol) and 8.775 g of sodium chloride (150 mmol) made up to 1000 
ml with deionized water, to produce the required pH of 7.0. 
Solution's pH was measured by electrical pH-meter (TWT Metrohm, 
Germany). 
 
 
Preparation of red blood cells suspension 
 
Human blood was collected from a healthy individual with 46.7% 
hematocrit and added to four heparinized tubes. After centrifuging 
at 3000 rpm for 10 min (Hermle 230 ZA,Germany), plasma and 
buffy coat were removed and the erythrocytes were washed three 
times in at least five times of their volume with McIlvaine's buffer, 
pH = 7.0. Afterward, by adding McIlvaine's buffer, an erythrocyte 
suspension with 12% hematocrit was prepared and kept in 4°C for 
experiments (Gould et al., 2000). 
 
 
Hemolytic method 
 
A suspension of erythrocyte (200 µl) within a micro-tube was 
incubated for the required times with an equal volume of the test 
sample of surfactants mixture, including 52, 56, 58, 72 or 92, prepared 
in McIlvaine's buffer, at 25 and 37°C. After incubation, the mixtures 
were spun in a microcentrifuge at 3000 rpm for 35 s (Spectrafuge 
161M, England), and 200 µl of the resulting supernatants was 
added to 3 ml of Drabkin's reagent. To measure the amount of 
hemoglobin released, the absorbance of the samples was assessed at 
540 nm wavelength using spectrophotometer (Shimadzu 3100, 
Japan). Positive controls consisted of 200 µl of uncentrifuged mixtures 
of erythrocyte suspensions and 200 µl of buffer, which were added 
to 3 ml Drabkin's reagent to obtain a value for 100% haemolysis. A 
negative control, included to assess the level of spontaneous 
haemolysis, comprised 200 µl buffer mixed with 200 µl erythrocytes 
and after centrifugation for 35 s, a 200 µl sample of supernatant 
was added to 3 ml of Drabkin's reagent. Haemolysis percentage for 
each sample were calculated by dividing sample's absorbance on 
positive control absorbance (compete haemolysis) multiplied by 100 
(Gould et al., 2000). 
 
 
Determination of emulsification Index 
 
For estimation of the emulsification index, 5 ml of liquid paraffin was 
added to 5 ml of different concentrations of surfactants in a graduated 
tube and vortexed at high speed for 2 min. The emulsion stability 
was determined after 24 h. The E24 was calculated by measuring 
the emulsion layer formed (Carrillo et al., 1996). 
 
 
Foam formation activity 
 
Different concentrations of surfactants were dissolved with 5 ml 
disodium phosphate buffer and shaken with a vibrator for 5 s. The 
samples were put aside at 25°C for one minute. Foam activity was 
measured as foam height in graduated cylinder (Porter, 1994). 
 
 
Critical micelle concentration (cmc) 
 
For estimation of the cmc, surface tension was determined by 
tensiometer (KRUSS K100, Germany), (data not shown). 
 
 
RESULTS 
 
The results of haemolysis induced by the surfactants  are  
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Table 1. Hemolysis induced by Brijs 52, 56, 72 and 92 after 15 min at 25°C (n = 6). 
 
Conc. (mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) 
(Mean) ±SD 
H (%) 
(Mean) ±SD 
H (%) 
(Mean) ±SD 
H (%) 
(Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.20 0.115 0.10 0.115 0.00 0.200 0.28 0.153 
0.05 0.30 0.000 0.10 0.100 0.13 0.153 0.14 0.115 
0.1 0.40 0.058 0.10 0.100 0.13 0.173 0.28 0.208 
0.14 0.59 0.252 0.62 0.153 0.00 0.173 0.43 0.153 
0.2 1.19 0.208 0.10 0.231 0.13 0.208 0.85 0.361 
0.3 4.06 0.404 0.72 0.208 0.38 0.208 1.56 0.100 
0.4 26.96 1.311 0.62 0.100 0.25 0.058 1.42 0.231 
0.6 92.57 0.557 0.41 0.252 0.38 0.153 1.70 0.153 
1 97.22 1.206 0.72 0.153 1.27 0.208 1.85 0.208 
2 98.51 1.153 1.85 0.153 1.39 0.100 1.99 0.153 
4 99.01 0.896 2.06 0.252 2.15 0.153 2.41 0.153 
6 98.61 1.060 2.57 0.173 2.41 0.153 2.27 0.231 
10 99.21 1.054 2.98 0.208 2.41 0.252 2.70 0.231 
 
 
 
Table 2. Hemolysis induced by Brijs 52, 56, 72 and 92 after 30 min at 25°C (n = 6). 
 
Conc. 
(mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.40 0.153 0.00 0.058 0.00 0.173 0.14 0.153 
0.05 0.40 0.115 0.10 0.208 0.00 0.153 0.00 0.173 
0.1 0.60 0.200 0.10 0.173 0.00 0.115 0.28 0.153 
0.14 0.71 0.208 0.10 0.153 0.00 0.153 0.14 0.000 
0.2 0.91 0.321 0.21 0.115 0.00 0.321 0.57 0.153 
0.3 6.05 0.400 0.10 0.153 0.13 0.265 2.97 0.379 
0.4 72.28 0.252 0.21 0.173 0.13 0.058 3.39 0.153 
0.6 97.28 0.693 0.21 0.100 0.25 0.115 3.68 0.252 
1 98.69 0.306 1.14 0.153 0.51 0.000 3.96 0.208 
2 99.29 0.907 2.59 0.100 0.88 0.200 3.96 0.321 
4 99.60 0.907 4.56 0.252 2.90 0.200 4.10 0.300 
6 99.29 1.305 6.85 0.153 2.90 0.173 4.24 0.173 
10 99.50 0.513 7.37 0.265 3.16 0.252 4.24 0.100 
 
 
 
shown in Tables 1-6. Tables 1-3 are related to haemolysis 
after 15, 30 and 45 min (incubation temperature 25°C).  
Tables 4 - 6 are related to haemolysis after 15, 30 and 45 
min (incubation temperature 37°C). Results of emul-
sification index and foaming formation are presented in 
Tables 7 and 8, respectively. 
DISCUSSION 
 
Despite the fact that not all is known about surfactant’s 
hemolytic activity, it is proposed that it may consist of the 
following processes: Absorption of surfactant molecules 
on cellular surface,  penetration  of  surfactant  molecules  
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Table 3. Hemolysis induced by Brijs 52, 56, 72 and 92 after 45 min at 25°C (n = 6). 
 
Conc. 
(mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.40 0.100 0.00 0.000 0.14 0.231 0.00 0.100 
0.05 0.61 0.208 0.00 0.058 0.00 0.231 0.15 0.058 
0.1 0.61 0.153 0.10 0.100 0.14 0.153 0.00 0.000 
0.14 1.31 0.115 0.10 0.058 0.29 0.153 0.15 0.058 
0.2 1.41 0.306 0.10 0.173 0.29 0.058 1.05 0.153 
0.3 8.28 0.252 0.10 0.100 0.72 0.115 5.98 0.265 
0.4 77.78 0.666 0.21 0.289 1.30 0.100 5.83 0.100 
0.6 97.07 0.100 0.10 0.115 1.73 0.252 5.68 0.115 
1 97.27 1.767 2.15 0.115 3.03 0.265 6.28 0.153 
2 98.68 0.781 3.90 0.306 4.05 0.200 5.98 0.208 
4 98.38 0.458 5.44 0.321 6.50 0.153 5.98 0.000 
6 98.89 0.557 5.74 0.404 6.79 0.153 6.13 0.265 
10 99.09 0.404 8.31 0.115 7.08 0.153 6.58 0.289 
 
 
 
Table 4. Hemolysis induced by Brijs 52, 56, 72 and 92 after 15 min at 37°C (n = 6). 
 
Conc. 
(mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.51 0.115 0.00 0.058 0.24 0.153 0.29 0.100 
0.05 0.61 0.115 0.00 0.058 0.12 0.306 0.43 0.115 
0.1 0.51 0.121 0.10 0.058 0.24 0.058 0.29 0.200 
0.14 0.61 0.153 0.20 0.058 0.24 0.173 0.43 0.208 
0.2 1.73 0.458 0.31 0.265 0.37 0.058 0.86 0.208 
0.3 6.72 0.624 0.31 0.200 0.37 0.100 1.87 0.153 
0.4 49.39 0.493 0.31 0.153 0.37 0.100 2.44 0.115 
0.6 97.45 0.231 0.61 0.153 0.61 0.115 2.30 0.173 
1 99.39 1.015 1.33 0.153 0.98 0.200 2.15 0.300 
2 99.19 0.451 1.84 0.153 1.22 0.200 2.44 0.265 
4 98.98 0.954 2.66 0.153 2.08 0.153 2.87 0.200 
6 99.59 0.500 3.59 0.153 2.08 0.300 3.16 0.058 
10 99.90 0.100 4.20 0.252 2.20 0.208 3.44 0.252 
 
 
 
into cellular membrane, initiation of alterations within cellular 
membrane, increasing permeability of cellular membrane, 
gradual increase  of  osmotic  phenomenon  followed  by 
destruction of cellular membrane and haemolysis.  
According to the above explanation, two different 
effects from surfactants in hemolytic studies can be 
observed; the first one is increasing cellular membrane 
permeability and the latter is cellular lysis. Surfactants 
which induce haemolysis can alter the membrane perme-
ability for hemoglobin. This alteration occurs in a specific 
spectrum of the surfactant concentration while in lower 
concentrations hemolytic effects cannot be seen; in these 
concentrations, cellular membrane is permeable for low 
molecular weight molecules. Destruction due to surfactants 
is the result of cellular membrane breakage by alteration 
of structural molecules of the membrane. Subsequently, 
the membrane permeability for macro molecules similar 
to smaller molecules increases. In this chain reaction 
mechanism, surface active agents adhere to the erythrocyte 
surface and enter inside, changing the molecular structure 
of the membrane, which results in colloid-osmotic swelling 
of the erythrocyte and ultimately cellular rupture. Micelle 
production from surfactant molecules and membrane 
phospholipids leads to an increase in  membrane  perme-  
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Table 5. Hemolysis induced by Brijs 52, 56, 72 and 92 after 30 min at 37°C (n = 6). 
 
Conc. 
(mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.000 0.000 
0.01 0.30 0.153 0.10 0.173 0.12 0.100 0.14 0.153 
0.05 0.40 0.153 0.20 0.153 0.12 0.058 0.00 0.058 
0.1 0.61 0.153 0.10 0.100 0.12 0.208 0.14 0.100 
0.14 0.81 0.361 0.10 0.100 0.25 0.153 0.14 0.200 
0.2 1.01 0.289 0.71 0.115 0.37 0.252 1.70 0.153 
0.3 9.00 0.529 0.92 0.208 0.62 0.153 2.84 0.351 
0.4 74.72 0.569 1.02 0.100 0.37 0.153 3.40 0.058 
0.6 97.47 0.643 1.33 0.153 0.62 0.058 4.40 0.265 
1 98.08 0.252 1.73 0.153 1.00 0.252 5.53 0.173 
2 98.48 0.666 2.96 0.153 1.50 0.200 5.82 0.208 
4 99.80 0.379 5.31 0.265 4.99 0.173 5.82 0.379 
6 99.49 0.757 9.47 0.265 5.61 0.100 5.96 0.153 
10 99.19 0.961 10.20 0.252 6.48 0.153 5.96 0.153 
 
 
 
Table 6. Hemolysis induced by Brijs 52, 56, 72 and 92 after 45 min at 37 °C (n = 6). 
 
Conc. 
(mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD H (%) (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.81 0.361 0.00 0.100 0.13 0.173 0.14 0.265 
0.05 0.81 0.265 0.00 0.115 0.13 0.208 0.14 0.153 
0.1 0.91 0.058 0.00 0.100 0.13 0.058 0.14 0.100 
0.14 1.01 0.208 0.10 0.153 0.26 0.252 0.29 0.115 
0.2 1.31 0.200 0.10 0.000 0.26 0.100 1.72 0.208 
0.3 10.88 0.513 0.21 0.115 1.03 0.153 8.33 0.361 
0.4 95.77 1.308 0.21 0.058 1.16 0.252 8.33 0.265 
0.6 97.18 0.416 0.51 0.252 1.03 0.153 8.33 0.265 
1 98.39 0.757 2.05 0.321 1.03 0.400 8.91 0.361 
2 99.30 2.050 4.72 0.231 1.16 0.306 8.76 0.153 
4 98.39 0.436 5.74 0.153 5.14 0.458 8.76 0.153 
6 99.60 0.656 9.13 0.306 5.91 0.173 9.05 0.265 
10 99.30 0.702 10.15 0.321 7.58 0.451 9.48 0.058 
 
 
 
ability and colloid-osmotic lysis of the erythrocyte. The 
above mechanism highly depends on surfactant concen-
tration    and   temperature   and  by  increasing  in  these 
factors, the level of haemolysis increases. These effects 
support the idea of surfactant usage as an absorption 
enhancer (Zaslavsky et al., 1987; Kleszczynska et al., 
2005). 
Haemolysis is due to the destruction of red blood cells 
which resulted from the lysis of membrane lipid bilayer 
emulsion and cellular membrane destruction. As this 
haemolysis relates to the concentration and potency of 
surfactants, the model can be used for the evaluation of 
surfactants potency. Biological membranes consist of a 
lipid bilayer which surrounds the whole cell surface and 
the proteins. Lipid bilayer structure is stabilized by non-
covalent bonds among acyl groups and ionic bonds 
between polar heads and aqua. In non-ionic surfactants, 
the interaction with biological membranes needs hydro-
phobic interaction between alkyl chains of surfactant and 
lipoprotein parts of membrane (Swenson and Curatolo, 
1992).  
In this study, the hemolytic effects of surfactants 
increased as temperature increased. Note that the liquid 
characteristic and fluidity of the  bilayer  lipid is one  of  its  
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Table 7. Emulsification index at different concentration of Brijs 52, 56, 72 and 92 (n = 6). 
 
Conc. (mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
E24 (Mean) ±SD E24 (Mean) ±SD E24 (Mean) ±SD E24 (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.05 9.09 0.658 0.00 0.000 0.00 0.000 0.00 0.000 
0.1 38.74 0.599 0.00 0.000 0.00 0.000 0.00 0.000 
0.14 53.17 0.687 0.00 0.000 0.00 0.000 0.00 0.000 
0.2 53.57 0.000 0.00 0.000 0.00 0.000 1.18 0.000 
0.3 53.75 0.318 0.00 0.000 0.00 0.000 1.18 0.006 
0.4 53.97 0.687 0.00 0.000 0.00 0.000 1.18 0.006 
0.6 53.57 0.000 4.74 0.029 1.19 0.000 1.18 0.006 
1 54.55 0.370 5.77 0.306 1.19 0.006 1.19 0.010 
2 55.16 0.687 6.30 0.662 1.19 0.006 1.19 0.006 
4 60.30 0.612 6.37 0.668 1.19 0.000 1.19 0.006 
6 62.20 0.260 6.39 0.647 1.20 0.006 1.19 0.000 
10 63.14 0.681 6.74 0.625 1.19 0.006 1.19 0.006 
 
 
 
Table 8. Foam formation activity at different concentration of Brijs 52, 56, 72 and 92 (n = 6). 
 
Conc. (mM) 
Surfactant 
Brij 56 Brij 52 Brij 72 Brij 92 
Fh24 (Mean) ±SD Fh24 (Mean) ±SD Fh24 (Mean) ±SD Fh24 (Mean) ±SD 
0 0.00 0.000 0.00 0.000 0.00 0.000 0.00 0.000 
0.01 2.33 0.289 0.50 0.000 0.67 0.289 0.00 0.000 
0.04 10.50 0.500 2.50 0.000 3.33 0.289 1.67 0.289 
0.08 15.00 0.500 4.00 0.500 5.00 0.500 1.83 0.289 
0.12 15.83 0.289 4.33 0.289 6.00 0.500 2.33 0.289 
0.16 17.83 0.289 6.00 0.000 9.17 0.289 2.33 0.289 
0.2 20.50 0.500 6.33 0.289 9.33 0.289 2.50 0.000 
0.4 19.00 0.000 7.50 0.000 14.00 0.500 3.00 0.500 
0.6 20.33 0.289 9.33 0.289 14.50 0.500 3.00 0.000 
0.8 20.00 0.500 9.67 0.289 15.83 0.289 3.17 0.289 
1 19.83 0.577 10.00 0.000 16.83 0.289 3.33 0.289 
 
 
 
special features. Therefore, some parts of the membrane 
can easily move throughout the surface. This charac-
teristic is due to membrane phospholipids which covert to 
jelly in temperatures lower than the physiologic tempe-
rature. This conversion of phospholipids helps in more 
stabilized and regular membranes and increases their 
resistance. As a result, the amount of haemolysis at 37°C 
is more than at 25°C. The reason is that with the increase 
in temperature, the membrane fluidity, and accordingly its 
permeability, increases (Zaslavsky et al., 1987).  
In solutions with higher concentration of surfactants, 
haemolysis amounts were more. This result can be easily 
described by Fick's law which states that, the diffusion 
flux from a membrane is proportional to the concentration 
difference between both sides (Muranishi, 1990). In other 
words, the concentration of intra-membrane surfactant is 
related to its extra-membrane concentration and by 
increasing the latter concentration, the first one increases 
until it reaches a specific concentration which leads to 
membrane destruction and hemolytic effects (Zaslavsky 
et al., 1987).   
The first step in surfactant-membrane interaction is 
membrane saturation with surfactant's monomers; following 
this, process cellular lysis is possible. The onset is 
followed by destruction and deconstruction of surfactant-
protein-lipid complexes and surfactant-lipid mixture micelles. 
Adding more surfactant enriches the surfactant-protein-lipid 
complexes and more mixture micelle pro-duction. At the 
extremity and in cmc, the amount of protein-surfactant 
complexes,   mixture   micelles  and   surfactant's  micelles 
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Table 9. Comparison of different Brijs based on of their properties. 
 
Properties of Brijs Different kind of Brijs 
HLB B56>B52>B72=B92 
Alkane chain length B72=B92>B52=B56 
Weight of hydrophile/Weight of liphophile B56>B52>B72=B92 
% Hemolysis (37°C )   B56> B52> B92>B72 
% Hemolysis (25°C)  B56> B52> B92>B72 
Foam formation activity B56>B72>B52>B92 
Emulsification index B56>B52>B72=B92 
 
 
 
become balanced with free surfactant (Schott, 1995). Our 
results showed that the hemolytic effects of surfactants 
increase as the latency of incubation and the amount of 
contact duration with erythrocytes increase. It is reported 
that the more the contact duration of erythrocytes with a 
solution, including a surface active agent solution, the 
more the amount of cellular lysis (Tragner and Csordas, 
1987). 
Adherence of surface active agents to erythrocyte's 
membrane which is followed by their entrance leads to an 
alteration of the molecular structure of the membrane, 
osmotic-colloid swelling and erythrocyte membrane 
rupture. The above mechanism depends on surfactant 
concentration, temperature and duration of contact with 
erythrocyte; and by increasing these factors, membrane 
permeability and haemolysis, that happen due to micelle 
production from surfactant and membrane phospholipids 
bilayer increases (Araki and Rifkind, 1981). 
Another aspect of this study was to evaluate the 
membrane toxicity of surfactants. As the agents or any 
other substance which have the ability to destroy the 
erythrocytes membrane can have similar effects on other 
cell membranes, evaluating erythrocytes membrane 
stability is a proper criterion for the determination of 
surfactant toxicity. Further, haemolysis was observed by 
increasing the incubation period and temperature. In 1 
mM and temperature of 37°C, Brij 56 caused 99.39% of 
erythrocytes destruction, while, 52, 72 and 92 caused 
56.31, 1.83, 1.33, 0.98 and 2.15% of destruction, respec-
tively. Moreover, Brij 56 induced almost 100% 
haemolysis while Brij showed the least destructive 
effects, respectively. The hemolytic activity of surfactants 
in this study increase in higher concentrations and at the 
critical concentration for micelle formation reached its 
utmost, and after this point remained steady.  Hence, the 
ability to increase membrane permeability and after its 
osmotic cellular lysis are due to mixture micelle formation 
in the bilayer membrane. Evaluating the erythrocyte 
haemolysis showed that Brij 72 had lower destruction 
level and less toxicity on cellular membranes. Erythrocyte 
haemolysis method is used to evaluate surfactant and 
cellular membrane interactions, enhancing activity and 
emul-sifying ability. Accordingly, Brij 72 with lower toxicity 
should be preferred for use as surface active agent and 
more studies on its enhancing abilities and formulatory 
properties are required. We showed that Brij 56 with low 
hydrophobic and high hydrophilic properties has more 
capability for membrane destruction, while Brij 72 with 
lower hydrophobic properties has less destruction capa-
bility. The haemolytic effects of some non-ionic surface 
active agents was evaluated and reported. In a series of 
surfactants from one family, the ones with the higher 
hydrophobic contents and lower hydrophile-lipophile 
balance (HLB) had lower haemolysis (Schott, 1995). 
According to the results (Table 9), it can be concluded 
that higher content of the hydrophobic part may lead to a 
reduction in permeability and hemolytic effects. Another 
potential property of surface active agents is their ability 
in induction and stabilizing emulsions. Emulsifying index 
has a direct relationship with surface tension and agent 
ability in micelle production. In this study, increasing the 
concentration of all surfactants leads to an increase in 
emulsion stability; however, this trend was not the same 
in all surfactants (Table 7). This effect started in low 
concentration (0.01 mM) and reached its maximum at 10 
mM. According to hemolytic data and emulsifying index, 
Brij 72 had the least toxicity and the best properties for 
emulsification to be used in formulations. Foaming ability 
of surfactants is a property which may help prove the 
existence of surfactants in a solution. Furthermore, this 
ability can be used in order to compare the detergency 
properties of detergents with high ability of foam production.  
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